Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

4.14
-0.0900-2.13%
Post-market: 4.140.00000.00%19:30 EDT
Volume:762.57K
Turnover:3.19M
Market Cap:129.54M
PE:-1.00
High:4.29
Open:4.23
Low:4.12
Close:4.23
52wk High:50.40
52wk Low:4.12
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.00
T/O Rate:4.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.59
PE(LYR):-1.45

Loading ...

Ovid Therapeutics price target raised to $5 from $4 at H.C. Wainwright

TIPRANKS
·
Sep 11

Outlook Therapeutics is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Sep 11

Serina Therapeutics: Early SER-252 Efficacy Signal and Strategic Positioning Support Unchanged $8 Price Target and Buy Rating

TIPRANKS
·
Sep 11

Xcell Therapeutics Trims Board as Independent Director Resigns

TIPRANKS
·
Sep 11

PYC Therapeutics Says First Patient Dosed in Open-Label Extension of Drug Candidate Study in Polycystic Kidney Disease

MT Newswires Live
·
Sep 11

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus After OSC Review

TIPRANKS
·
Sep 11

Whitehawk Therapeutics Adds Oncology Leader to Board

TIPRANKS
·
Sep 11

Cardiol Therapeutics files $150M preliminary base shelf prospectus

TIPRANKS
·
Sep 11

Press Release: Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors

Dow Jones
·
Sep 11

Serina Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 11

Private Markets: Gimlet Labs, Encoded Therapeutics secure new funding

TIPRANKS
·
Sep 11

Kazia Therapeutics Price Target Maintained with a $40.00/Share by BTIG

Dow Jones
·
Sep 10

Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire
·
Sep 10

CAMP4 Therapeutics Receives Authorization in the United Kingdom for Phase 1/2 Human Clinical Trial of CMP-002 in Patients with SYNGAP1-Related Disorder

GlobeNewswire
·
Sep 10

Indaptus Therapeutics Announces Private Equity Financing Deal

TIPRANKS
·
Sep 10

Neurizon Therapeutics Redeems 1 Million Convertible Notes From Obsidian for Over $1 Million; Shares Fall 8%

MT Newswires Live
·
Sep 10

Top Executive Makes Eye-Catching Move at Denali Therapeutics

TIPRANKS
·
Sep 10

Cathie Wood’s ARK Investment buys 271K shares of Beam Therapeutics today

TIPRANKS
·
Sep 10

Summit Therapeutics Raised to Buy from Hold by Jefferies

Dow Jones
·
Sep 10

Rallybio CFO Transition Amid Pending Avenzo Therapeutics Merger

TIPRANKS
·
Sep 10